Track the 티움바이오 stock price and the full insider trade history of the company, a listed issuer based in South Korea. Shares are listed on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 티움바이오 has published 13 public disclosures. The latest transaction was disclosed on 22 April 2022 (Sale). Among the most active insiders: 김훈택. All data is openly available.
13
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
4 ops.
Sell Volume
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.